|Bid||697.50 x 1330000|
|Ask||698.50 x 40300|
|Day's range||697.50 - 707.50|
|52-week range||594.99 - 807.49|
|PE ratio (TTM)||30.61|
|Dividend & yield||N/A (N/A)|
|1y target est||695.82|
BEAUFORT, S.C.--(BUSINESSWIRE)-- A new analysis published by THE SAGE GROUP concludes that atherosclerotic peripheral arterial disease (PAD) afflicts 8-10 million in Japan. “Although it is commonly believed that PAD is a ‘Western’ disease with a significantly lower prevalence in Asians, our research indicates this is not the case,” stated Mary L. Yost, President of THE SAGE GROUP. “We believe that PAD prevalence is only modestly lower.
The Sage Group plc 5 January 2017 Notice of Annual General Meeting Copies of the Notice of Annual General Meeting to be held on 28 February 2017, together with a related Proxy Form, have been submitted ...
The Sage Group plc. ('the Company') 23 December 2016 In conformity with rule 5.6.1 of the Financial Conduct Authority's Disclosure and Transparency Rules (the DTRs) we would like to notify the market of ...